Legal Protection against Patent and Intellectual Property Rights Violations Amidst COVID-19

Wachiraporn Poungjinda, Shubham Pathak, Ivan Bimbilovski


The concept of legal principles for intellectual property (IP) protection is related to the adequate marketing of drug patents to protect patent rights. The objective of this research is to understand and analyze the factors affecting the market concerning international law, treaties, acts, and declarations, leading to encouraging creativity, production, increased investment, especially amidst the COVID-19 pandemic. The qualitative methodology provided for an in-depth understanding and analysis of primary and secondary research data gathered from key informant interviews and published literature. The collected data were analyzed with Strength, Weakness, Opportunity, and Threats (SWOT), a Delphi panel, and Correct, Adapt, Maintain, and Explore (CAME) analysis. The results found legal problems concerning the lack of rules to protect the rights and freedoms damaged by the monopoly on drug patents, complexities in the process of importing medicinal compounds, and how to access information with limited accessibility during COVID-19. Therefore, it is advisable to amend the law to curtail monopolies and to enact a law that prescribes rules for importing medicinal compounds to produce generic drugs in the country, including identifying the status of the patent holders. The research further paves the way for utilizing micro level research to be conducted in the development of intellectual property rights.


Doi: 10.28991/ESJ-2023-SPER-016

Full Text: PDF


Patent Rights; Drug Market; Liability to Patent Right Holders; Intellectual Property Rights; World Trade Organization (WTO); Free Trade Agreements (FTAs); World Intellectual Property Organisation (WIPO).


Adkisson, R. V. (2004). Intellectual Property Rights in the Global Economy. Journal of Economic Issues, 38(1), 281–282. doi:10.1080/00213624.2004.11506680.

Junod, V. (2004). Drug marketing exclusivity under United States and European Union law. Food and Drug Law Journal, 59(4), 479–518.

Reichman, J. H. (1996). From Free Riders to Fair Followers: Global Competition Under the TRIPS Agreement. New York University Journal of International Law & Politics, 29, 11.

Zappalaglio, A. (2022). Getting Article 22(1) TRIPS Right: A Commentary on the Definition of ‘Geographical Indication’ from a European Union Perspective with a Focus on Wines. The Journal of World Investment & Trade, 23(2), 180–217. doi:10.1163/22119000-12340246.

Braga, C. A. P., Fink, C., & Sepulveda, C. P. (2000). Intellectual property rights and economic development. World Bank Discussion Papers No. 412, World Bank Publications, Washington, United States.

Cavagnero, S., & Giordano, S. (2022). Sui Generis Geographical Indications Fostering Localized Sustainable Fashion: A Cross-Industry Assessment. Sustainability (Switzerland), 14(9), 5251. doi:10.3390/su14095251.

Arunanondchai, J., & Fink, C. (2006). Trade in health services in the ASEAN region. Health Promotion International, 21(Suppl_1), 59–66. doi:10.1093/heapro/dal052.

Payyappallimana Unnikrishnan. (2010). Role of Traditional Medicine in Primary Health Care- An Overview of Perspectives and Challenges. Yokohama Journal of Social Sciences, 14(August), 57–77.

Tenni, B., Moir, H. V. J., Townsend, B., Kilic, B., Farrell, A.-M., Keegel, T., & Gleeson, D. (2022). What is the impact of intellectual property rules on access to medicines? A systematic review. Globalization and Health, 18:40. doi:10.1186/s12992-022-00826-4.

Yoongthong, W., Hu, S., Whitty, J. A., Wibulpolprasert, S., Sukantho, K., Thienthawee, W., Han, H., & Scuffham, P. A. (2012). National Drug Policies to Local Formulary Decisions in Thailand, China, and Australia: Drug Listing Changes and Opportunities. Value in Health, 15(1), S126–S131. doi:10.1016/j.jval.2011.11.003.

Ngorsuraches, S., & Chaiyakan, K. (2015). Equitable Prices of Single-Source Drugs in Thailand. Applied Health Economics and Health Policy, 13(4), 389–397. doi:10.1007/s40258-015-0165-6.

Niëns, L. M., & Brouwer, W. B. F. (2013). Measuring the affordability of medicines: Importance and challenges. Health Policy, 112(1–2), 45–52. doi:10.1016/j.healthpol.2013.05.018.

Kuanpoth, J. (2015). Intellectual property and transparency in trade negotiations: The experience of Thailand. Journal of Intellectual Property Rights, 20(2), 112–121.

Maskus, K. E. (1998). The role of intellectual property rights in encouraging foreign direct investment and technology transfer. Duke Journal of Comparative & International law, 9, 109-161.

Puasiri, W. (2013). Patent Registration and Innovations in Thailand: Impediments or Improvements?. Thammasat Review, 16(1), 215-228.

Sereebenjapol, P. (2010). Copyright perspectives from Thailand. Community and Junior College Libraries, 16(1), 37–46. doi:10.1080/02763910903479353.

Phimolsathien, T. (2018). Development of Guidelines for the System of Intellectual Property Management: Geographical Indication in Each Age Range. Asian Administration & Management Review, 1(1).

Forman, L. (2012). From TRIPS-Plus to Rights-Plus: Exploring Right to Health Impact Assessment of Trade-Related Intellectual Property Rights through the Thai Experience. Asian Journal of WTO and International Health Law and Policy, 7(2), 347-375.

Reichman, J. H. (2009). Rethinking the Role of Clinical Trial Data in International Intellectual Property Law: The Case for a Public Goods Approach. SSRN Electronic Journal. doi:10.2139/ssrn.1433392.

Haley, G. T., & Haley, U. C. V. (2012). The effects of patent-law changes on innovation: The case of India’s pharmaceutical industry. Technological Forecasting and Social Change, 79(4), 607–619. doi:10.1016/j.techfore.2011.05.012.

Daengprasert, S., Sutanthavibul, N., & Chandrachai, A. (2012). Development Process for Thai Traditional Medicines. Journal of Medical and Bioengineering, 1(1), 11–13. doi:10.12720/jomb.1.1.11-13.

Howard, L. (2009). Strategie use of Supplementary Protection Certificates (Part 1). Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, 6(3), 284–291. doi:10.1057/jgm.2009.18.

Kutik, S. (2019). Strategies for medicinal product SPCs in Europe. Journal of Intellectual Property Law & Practice, 14(6), 438–444. doi:10.1093/jiplp/jpz026.

Menell, P. S. (1999). Intellectual property: General theories. Encyclopedia of Law and Economics, 2, 129-188.

Dratler Jr, J., & McJohn, S. M. (2023). Intellectual property law: Commercial, creative and industrial property. Law Journal Press, New York, United States.

Chapman, A. R. (2002). The human rights implications of intellectual property protection. Journal of International Economic Law, 5(4), 861–882. doi:10.1093/jiel/5.4.861.

Kristin, D., & Dewi, C. T. I. (2022). The Dilemma in COVID-19 Pandemic: The Protection of Intellectual Property Rights or A Life? Media Iuris, 5(2), 189–206. doi:10.20473/mi.v5i2.34349.

Parra Santiago, J. I., & Camarero, A. (2020). Puesta en valor de infraestructuras logísticas con utilización de la metodología DAFO-Delphi-CAME. El caso de la plataforma logística ferroviaria de Albacete. Ingeniería Y Competitividad, 23(1). doi:10.25100/iyc.v23i1.9006.

Kiewnin, K., Boontantrapiwat, T., Sosom, J., Hongtumrong, M., Khunakorncharatphong, A., Kanchanachitra, C., & Pachanee, C. A. (2021). International trade and health in thailand: A scoping review. International Journal of Environmental Research and Public Health, 18(21), 11692. doi:10.3390/ijerph182111692.

Mitchell, A. D., Taubman, A. S., & Samlidis, T. (2023). Intellectual Property and Vaccine Manufacturing: Utilising Existing TRIPS Agreement Flexibilities for COVID-19 and other Public Health Crises. Tulane Journal of Technology & Intellectual Property, 25.

Nillsuwan, B. (2022). Imbalance Between Public Health and Intellectual Property Rights Protection Goals: Battles on AIDS Medicines in Thailand. Globalisation and Local Conflicts in Africa and Asia. Evidence-Based Approaches to Peace and Conflict Studies, 7, Springer, Singapore. doi:10.1007/978-981-16-8818-8_7.

Antons, C., & Blakeney, M. (2023). Intellectual property, creativity and innovation in ASEAN. Intellectual Property Law in South East Asia, 1-16, Edward Elgar Publishing, Cheltenham, United Kingdom. doi:10.4337/9781035308392.00005.

Garcia, G. (2023). Intellectual property rights in South East Asian least developed countries: The cases of Cambodia, the Lao Peoples Democratic Republic, and Myanmar. Intellectual Property Law in South East Asia, 175-215, Edward Elgar Publishing, Cheltenham, United Kingdom. doi:10.4337/9781035308392.00011.

Cuesta-García, A., Fernández-Lansac, V., & Crespo, M. (2023). Barriers to access intimate partner violence services in female Romanian immigrants in Spain: A Delphi study. Journal of Community Psychology, 51(1), 297–318. doi:10.1002/jcop.22904.

Peterson, E. (2018). Techniques for Addressing Managerial Attitudes toward Lawyers and the Law. Southern Law Journal, 28(1), 1-25.

Sánchez-Cambronero, A., González-Cancelas, N., & Serrano, B. M. (2020). Analysis of port sustainability using the PPSC methodology (PESTEL, Porter, SWOT, CAME). World Scientific News, (146), 121-138.

Kosmidis, K., Argyrakis, P., & Macheras, P. (2003). A reappraisal of drug release laws using Monte Carlo simulations: The prevalence of the Weibull function. Pharmaceutical Research, 20(7), 988–995. doi:10.1023/A:1024497920145.

Napaporn, J., Buakaew, P., Suksakornthanawat, P., Sripa, S., Jinatongthai, P., & Supapaan, T. (2022). Analogous comparison of registered brand name drugs of tablets and capsules commercially available in Thailand: A retrospective study. PLOS ONE, 17(10), e0276321. doi:10.1371/journal.pone.0276321.

Wongburanavart, A. (2023). Traditional Knowledge and Intellectual Property Protection: Challenges and Opportunities in Thailand. The Journal of Law, Public Administration and Social Science. School of Law Chiang Rai Rajabhat University, 7(1), 47-71.

Motohashi, K. (2020). Development of patent database in Thailand for assessing local firms’ technological capabilities. World Patent Information, 63, 101998. doi:10.1016/j.wpi.2020.101998.

Ray, A., Tripathi, S., & Rai, A. (2019). Pharmaceuticals Export and Market Evolution in India and Thailand. Trends in Biosciences, 12(1), 1–20.

Drahos, P. (2008). “Trust me” Patent offices in developing countries. American Journal of Law and Medicine, 34(2–3), 151–174. doi:10.1177/009885880803400205.

Sinnreich, A. (2019). The Essential Guide to Intellectual Property. Yale University Press, New Haven, United States. doi:10.2307/j.ctvgc628g.

Zermeño-Guerrero, J., Garza-Ruiz, M., & Rodríguez-Padilla, M. C. (2021). Knowledge on intellectual property as an advantage for scientific research. Inquietud Empresarial, 21(1), 103–116. doi:10.19053/01211048.11533.

Ding, Q., Gao, S., Zhu, J., & Yuan, C. (2020). Permissioned Blockchain-Based Double-Layer Framework for Product Traceability System. IEEE Access, 8(5), 6209–6225. doi:10.1109/ACCESS.2019.2962274.

Correa, C. M. (2005). Implementing the Trips Agreement in the Patents Field. The Journal of World Intellectual Property, 1(1), 75–99. doi:10.1111/j.1747-1796.1998.tb00004.x.

Elnaiem, A., Mohamed-Ahmed, O., Zumla, A., Mecaskey, J., Charron, N., Abakar, M. F., Raji, T., Bahalim, A., Manikam, L., Risk, O., Okereke, E., Squires, N., Nkengasong, J., Rüegg, S. R., Abdel Hamid, M. M., Osman, A. Y., Kapata, N., Alders, R., Heymann, D. L., … Dar, O. (2023). Global and regional governance of One Health and implications for global health security. The Lancet, 401(10377), 688–704. doi:10.1016/s0140-6736(22)01597-5.

Ritter, A. (2009). How do drug policy makers access research evidence? International Journal of Drug Policy, 20(1), 70–75. doi:10.1016/j.drugpo.2007.11.017.

Mcbride, D. C., Terry-Mcelrath, Y., Harwood, H., Inciardi, J. A., & Leukefeld, C. (2009). Reflections on drug policy. Journal of Drug Issues, 39(1), 71–88. doi:10.1177/002204260903900107.

Full Text: PDF

DOI: 10.28991/ESJ-2023-SPER-016


  • There are currently no refbacks.

Copyright (c) 2022 Wachiraporn Poungjinda, Shubham Pathak, Ivan Bimbilovski